UBS Group
SLGC

UBS Group’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

UBS Group’s Portfolio SLGC Stock Details SLGC Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
2023
Q4 		$473K Buy
2023
Q3 		$276K Sell
2023
Q2 		$272K Buy
2023
Q1 		$183K Buy
2022
Q4 		$149K Buy
2022
Q3 		$29K Sell
2022
Q2 		$94K Sell
2022
Q1 		$1.01M Buy
2021
Q4 		$110K Buy
2021
Q3 		$58K Buy